MedPath

Testozole

Testozole 60mg/4mg

Approved
Approval ID

d3c42530-07dd-8a7d-e053-2a95a90ab2b6

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

May 27, 2022

Manufacturers
FDA

Advanced Pharmaceutical Technology, Inc.

DUNS: 023237884

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Testosterone,USP

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code57377-060
Product Classification
G
Generic Name
Testosterone,USP
Product Specifications
Route of AdministrationSUBCUTANEOUS
Effective DateMay 27, 2022
FDA Product Classification

INGREDIENTS (4)

STEARIC ACIDInactive
Code: 4ELV7Z65AP
Classification: IACT
TESTOSTERONEActive
Quantity: 60 mg in 1 1
Code: 3XMK78S47O
Classification: ACTIB
POVIDONEInactive
Code: FZ989GH94E
Classification: IACT
ANASTROZOLEActive
Quantity: 4 mg in 1 1
Code: 2Z07MYW1AZ
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.